Canon Medical is launching new X-ray advances at the Radiological Society of North America (RSNA) 2025 annual meeting.

Pulmonary embolism (PE) treatment has evolved over time, yet it remains the third leading cause of cardiovascular death across the United States. TriStar Health, a comprehensive health system serving Tennessee and Kentucky and part of HCA Healthcare, is now using an AI platform to support clinicians in providing more effective care for PE patients.

The standard of care for diagnosing coronary artery disease (CAD) has changed. CCTA paired with AI-powered Plaque Analysis has emerged as a tool of choice to identify, risk stratify and stage CAD, and notably, manage and treat patients in a far more informed way. Join us to hear from three key opinion leaders as they present data and new case studies demonstrating how Plaque Analysis can help with diagnosis and management of patients with suspected CAD. One physician even shares how he has benefitted from CCTA + Plaque Analysis. It’s a great story.

We all know that imaging data is growing at an unprecedented pace with AI accelerating the curve. For healthcare organizations, this means more pressures on storage, infrastructure, performance and long-term planning. Our panel of imaging leaders will introduce a new model that rethinks how imaging data is stored and accessed, with the goal of supporting both innovation and cost predictability. 

When UCSF Health’s enterprise imaging team needed to bring two new Dignity Health hospitals into their network, a new data migration project was born. Even after many migrations over many years, there are always new ways to innovate, so say Director of Enterprise Imaging Neil Singh and Enterprise Imaging Architect Roman Bitner-Glindzicz.

Listen in now to this webinar that explores the MEDRAD® Centargo CT Injection System, Bayer’s multi-patient injector designed to enhance workflow efficiency in high-throughput CT suites.

Join us for an engaging peer discussion on in-house 3D post-processing. Discover how top programs nationwide are evolving their labs and leveraging advanced visualization software, AI, and automation to enhance efficiency for both physicians and technologists.

Listen in as a general cardiologist, surgeon, and interventionalist delve into the latest evidence—including the Evolut™ TAVR 5-Year Low Risk data and SMART Trial 2-Year update—to guide appropriate treatment decisions for patients with severe symptomatic aortic stenosis.